Vincenzo Graziano Maria Teresa Scognamiglio Marinella Zilli Jamara Giampietro Patrizia Vici Clara Natoli Antonino Grassadonia
10.1080/15384047.2015.1108490
Cancer Biol Ther
2015;16(12):1704-9.
breast cancer immune privilege immune response immune tolerance pertuzumab skin metastases trastuzumab
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/26552483/
Breast Neoplasms / pathology Receptor, ErbB-2 / antagonists & inhibitors Skin Neoplasms / secondary
Breast Neoplasms / pathology Receptor, ErbB-2 / antagonists & inhibitors Skin Neoplasms / secondary Case Reports Research Support, Non-U.S. Gov't Antineoplastic Agents / pharmacology Antineoplastic Agents / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Biopsy Breast Neoplasms / diagnosis Breast Neoplasms / drug therapy Female Humans Magnetic Resonance Imaging Middle Aged Neoplasm Staging Receptor, ErbB-2 / genetics Receptor, ErbB-2 / metabolism Skin Neoplasms / diagnosis Tomography, X-Ray Computed Trastuzumab / pharmacology Trastuzumab / therapeutic use Antineoplastic Agents Receptor, ErbB-2 Trastuzumab
PMC4847805
26552483
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?
2015